Novo Nordisk Aktie
44,35
EUR
-0,52
EUR
-1,16
%
44,34
EUR
-0,67
EUR
-1,49
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk Aktie Analyse
| 22.08.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.08.16 | Novo Nordisk buy | Citigroup Corp. | |
| 09.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.08.16 | Novo Nordisk Neutral | Credit Suisse Group | |
| 08.08.16 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 08.08.16 | Novo Nordisk Hold | Deutsche Bank AG | |
| 05.08.16 | Novo Nordisk Hold | Commerzbank AG | |
|
Werbung
|
|||
| 02.08.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 27.07.16 | Novo Nordisk buy | Citigroup Corp. | |
| 25.07.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 18.07.16 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.07.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 13.07.16 | Novo Nordisk overweight | Morgan Stanley | |
| 13.07.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.07.16 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 29.06.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.06.16 | Novo Nordisk buy | Citigroup Corp. | |
| 15.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.06.16 | Novo Nordisk buy | Citigroup Corp. | |
| 14.06.16 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.06.16 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 14.06.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 13.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.06.16 | Novo Nordisk overweight | Morgan Stanley | |
| 09.06.16 | Novo Nordisk buy | Baader Wertpapierhandelsbank | |
| 26.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.05.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.16 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.05.16 | Novo Nordisk buy | Citigroup Corp. | |
| 03.05.16 | Novo Nordisk Halten | Independent Research GmbH | |
| 03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.05.16 | Novo Nordisk overweight | Barclays Capital | |
| 29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.04.16 | Novo Nordisk overweight | Morgan Stanley | |
| 18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.04.16 | Novo Nordisk Hold | Deutsche Bank AG | |
| 29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 15.03.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk Sell | UBS AG | |
| 07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
Werbung